血浆促酰化蛋白在评价儿童肥胖症发展中的意义
被引量：1
Significance of plasma acylation stimulating protein in evaluation of obesity progress in children
出处
《中华儿科杂志》
CAS
CSCD
北大核心
2005年第2期142-143,共2页
Chinese Journal of Pediatrics
基金
国家自然科学基金(30170442)
国家自然科学基金国际交流与合作项目(30311120163)
参考文献5
-
1Ciaflone K, Roncari DA K, Maslowska M, et al. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry, 1994,33 : 489-495.
-
2Ciardlone K. The acylation stimulating protein pathway: clinical implications. Clin Biochem, 1997, 30: 301-312.
-
3Murray I, Kohl J, Ciantlone K. Acylation-stimulating protein(ASP) : Structure-function determinants of cell surface binding and triacylglycerol synthetic activity. Biochem J, 1999, 342Pt1 :41-48.
-
4Ciatlone K, Kalant D, Marliss EB, et al. Response of plasma ASP to a prolonged fast. Intl J Obesity, 1995,19: 604-609.
-
5Maslowska M, Vu H, Phelis S, et al. Plasma acylation stimulating protein, adiposin and lipids in non-obese and obese populations. Eur J Clin Invest, 1999,29 : 679-686.
同被引文献20
-
1卢慧玲,王宏伟,Katherine Cianflone,温宇,林汉华.肥胖症儿童血浆脂联素、促酰化蛋白水平变化的临床意义[J].中华内分泌代谢杂志,2004,20(6):499-501. 被引量：7
-
2米杰,程红,侯冬青,段佳丽,滕红红,王友发.北京市2004年2-18岁儿童青少年超重和肥胖流行现状[J].中华流行病学杂志,2006,27(6):469-474. 被引量：135
-
3Kuczmarski RJ,Ogden CL,Grummer-Strawn LM,et al.CDC growth charts:United States.Adv Data,2000,(314):1-27.
-
4Cook S,Weitzman M,Auinger P,et al.Prevalence of a metabolic syndrome phenotype in adolescents:findings from the third National Health and Nutrition Examination Survey,1988-1994.Arch Pediatr Adolesc Med,2003,157(8):821-827.
-
5Zimmet P,Alberti KG,Kaufman F,et al.The metabolic syndrome in children and adolescents--an IDF consensus report.Pediatr Diabetes,2007,8(5):299-306.
-
6Weyer C,Tataranni PA,Pratley RE.Insulin action and insulinemia are closely related to the fasting complement C3,but not acylation stimulating protein concentration.Diabetes Care,2000,23(6):779-785.
-
7Yang Y,Lu HL,Zhang J,et al.Relationships among acylation stimulating protein,adiponectin and complement C3 in lean vs obese type 2 diabetes.Int J Obes (Lond),2006,30(3):439-446.
-
8Cianflone K,Zhang XJ,Genest J Jr,et al.Plasma acylation-stimulating protein in coronary artery disease.Arterioscler Thromb Vasc Biol,1997,17(7):1239-1244.
-
9Hernández-Mijares A,Jarabo-Bueno MM,López-Ruiz A,et al.Levels of C3 in patients with severe,morbid and extreme obesity:its relationship to insulin resistance and different cardiovascular risk factors.Int J Obes (Lond),2007,31(6):927-932.
-
10Onat A,Uzunlar B,Hergenc G,et al.Cross-sectional study of complement C3 as a coronary risk factor among men and women.Clin Sci (Lond),2005,108(2):129-135.
二级引证文献4
-
1梁晓燕,吴静.3T3-L1脂肪细胞分化中促酰化蛋白对脂肪因子肾上腺髓质素mRNA表达的影响[J].实用儿科临床杂志,2011,26(19):1483-1485.
-
2许志刚,高颖.脂肪激素促酰化蛋白在心血管疾病中的研究进展[J].医学综述,2012,18(15):2345-2347.
-
3冯维良.促酰化蛋白水平与胎儿生长发育的关系研究[J].中国乡村医药,2012,19(18):37-38. 被引量：2
-
4杜俊文,吴韬,张坤,苏白玉,卢彩萍,王伟超,雷琳,郭静霞.血浆脂联素和促酰化蛋白水平与儿童肥胖症发病的关系[J].中国妇幼保健,2015,30(31):5386-5387. 被引量：1
-
1卢慧玲,王宏伟,赵华月.冠心病患者血浆促酰化蛋白与血脂关系的研究[J].中华心血管病杂志,2004,32(10):935-935.
-
2温宇,王宏伟,施虹,胡秀芬,程佩萱,魏俊.血浆促酰化蛋白、脂联素在川崎病早期诊断中的作用[J].实用儿科临床杂志,2004,19(11):933-935. 被引量：3
-
3郑俊虎,郑骆颖,冯维良,王靖,陈吉勇.血浆促酰化蛋白与巨大儿早期生长的关系[J].中国优生与遗传杂志,2014,22(10):95-96. 被引量：1
-
4石蕾.新生儿的脂肪代谢[J].国外医学（妇幼保健分册）,1996,7(4):176-179. 被引量：11
-
5生物化学和分子生物学检验与临床[J].中国医学文摘（检验与临床）,2005,19(1):6-25.
-
6梁晓燕,吴静.3T3-L1脂肪细胞分化中促酰化蛋白对脂肪因子肾上腺髓质素mRNA表达的影响[J].实用儿科临床杂志,2011,26(19):1483-1485.
-
7张斌,陈忠,姚顺芳,胡秀芬,王宏伟.儿童促酰化蛋白水平与肥胖的关系[J].华中医学杂志,2004,28(2):77-78.
-
8许志刚,高颖.脂肪激素促酰化蛋白在心血管疾病中的研究进展[J].医学综述,2012,18(15):2345-2347.
-
9李明,李振华.氟乙酰胺中毒时肝功能的变化[J].青海医药杂志,2000,30(9):6-7.
-
10冯天行.新生儿黄疸的病因及中西医治疗[J].中国医药导刊,2010,12(3):400-402. 被引量：5
